Example: Heart Attack
Clinical Trials on Glabellar Crease
Total 10000 results
-
NCT03052634CompletedAdvanced Breast Cancer
-
NCT01300962CompletedMetastatic Breast Cancer
-
NCT02422615Completed
-
NCT03297346Completed
-
NCT03262935Completed
-
NCT04265274Withdrawn
-
NCT06047184Active, not recruitingAdvanced Breast Cancer
-
NCT01975597TerminatedMetastatic Breast Cancer
-
NCT04262804Active, not recruiting
-
NCT01656538CompletedMetastatic Breast Cancer
-
NCT03555877Completed
-
-
NCT04979715Completed
-
NCT05833919Active, not recruiting
-
NCT05203497CompletedBreast Cancer Female
-
NCT05793710Completed
-
NCT01919749Completed
-
NCT00431704Active, not recruitingMetastatic Breast Cancer
-
NCT04058418CompletedFamilial Breast Cancer
-
NCT04826016Withdrawn
-
NCT00276120CompletedInvasive Breast Cancer
-
-
NCT05206656CompletedMetastatic Breast Cancer
-
NCT00270413CompletedMetastatic Breast Cancer
-
NCT05609903CompletedAtezolizumab With Nab-paclitaxel for Patients With Triple-negative Stage IV Breast Cancer (Anastase)Breast Cancer Metastatic
-
NCT05009849Active, not recruitingBreast Cancer Patients
-
NCT02444390Completed
-
NCT03836872TerminatedFemale Breast Cancer
-
NCT02594371Completed
-
NCT04436744Completed
-
NCT04436393Completed
-
-
NCT02909361Active, not recruitingMetastatic Breast Cancer
-
NCT03688204CompletedBreast Cancer Risk
-
NCT05213403Completed
-
NCT03975621CompletedMetastatic Breast Cancer
-
NCT00952692Completed
-
NCT03166085CompletedMetastatic Breast Cancer
-
NCT03499353Terminated
-
NCT04277338CompletedPrimary Breast Cancer
-
NCT04103853Completed
-
NCT03538171Active, not recruiting
-
NCT03982004TerminatedMetastatic Breast Cancer
-
NCT02505048Completed
-
NCT03581552CompletedBreast Cancer | Breast Cancer Female
-
NCT03046004Completed
-
NCT04829890CompletedBreast Cancer | Adenocarcinoma of Breast
-
NCT00442260Completed
-
NCT04212702UnknownMetastatic Breast Cancer
-
NCT01340495UnknownInvasive Breast Cancer
-
NCT04034589Unknown